General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov stands near the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4651x3294px, 10.1Mb
- Job-ID: bb5cc3060b9d8370